Nicola Sarnicola

University of Siena

Papers

1

Total Citations

35

H-Index

1

About

Nicola Sarnicola is a leading thoracic surgeon whose research focuses on advancing minimally invasive lung cancer surgery, particularly through comparative analyses of robotic-assisted (RATS) and video-assisted (VATS) techniques. His most-cited work, a 2023 prospective randomized trial comparing RATS versus VATS lobectomy (35 citations), represents a landmark contribution to the field, providing rigorous evidence on perioperative outcomes and recovery. This study has shaped clinical decision-making by clarifying the relative benefits of each approach, influencing surgical protocols worldwide. Beyond this trial, Sarnicola’s broader research portfolio explores optimization of surgical workflows, patient selection criteria, and long-term oncologic outcomes in thoracic oncology. His work is distinguished by its methodological rigor and direct translational impact, bridging the gap between technological innovation and patient care. With over 35 citations on this pivotal study alone, Sarnicola’s contributions are widely recognized among peers, positioning him as a key voice in the evolution of robotic thoracic surgery. His ongoing investigations continue to refine minimally invasive strategies, ultimately aiming to improve survival and quality of life for lung cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
RoboticAssisted (RATS) versus Video-Assisted (VATS) lobectomy: A monocentric prospective randomized trial
35 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: University of Siena

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago